Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Advisory
Statement on Pricing Transparency
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Request for Proposals (RFP)
Wholesale Pharmacy Distributor
A sample of wholesale pharmacy distributor request for proposal.
Request for Proposals (RFP)
Landscaping Services RFP
Sample landscaping services request for proposal (RFP).
Request for Proposals (RFP)
Furnishing, Installation of Furniture, Equipment RFP
Sample furnishing, installation of furniture, and equipment sample request for proposal. 
Request for Proposals (RFP)
Laundry Construction Consultant RFP
A sample of a laundry Construction, consultant RFP covering all the basics. Download the document and tailor it to your needs.
Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo